Antithrombotic therapy in the elderly - are there differences?

---

Atıf İçin Kopyala

Şahin M.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.45, ss.89-92, 2017 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 45
• Basım Tarihi: 2017
• Doi Numarası: 10.5543/tkda.2017.57607
• Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.89-92
• Anahtar Kelimeler: Antiplatelet therapy, elderly, PERCUTANEOUS CORONARY INTERVENTION, ELEVATION MYOCARDIAL-INFARCTION
• Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Atherothrombotic disease increase with age and that the prevalence of the elderly population is continuously growing. Antithrombotic therapy represents the cornerstone of prevention of atherothrombosis. The choice of the antithrombotic therapy in elderly patients remains an ongoing challenge. Althoug the benefits of antiplatelet therapy in the elderly are demonstrated, the elderly are generally more vulnerable to the adverse effects of antithrombotic drugs. Because of them, understanding strategies of antithrombotic management in elderly is important.